Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

JETi Lower Extremity Venous Thrombosis

NCT: NCT07027878 · COMPLETED

NCT IDNCT07027878
StatusCOMPLETED
Start Date2020-08-03
Completion2025-07-16

Brief Summary

The JETi Registry is a prospective, single-arm, multicenter study to collect real-world data on the safety, performance, and clinical benefits of the JETi System for the treatment of acute and subacute thrombosis in the peripheral vasculature. This is a post-market study that will register approximately 280 subjects at approximately 30 centers globally. Subjects participating in this registry will be followed through their 12-month follow up visit.

Frequently Asked Questions

What is JETi Lower Extremity Venous Thrombosis?

JETi Lower Extremity Venous Thrombosis is a clinical trial registered under NCT07027878. Current status: COMPLETED.

What is the status of NCT07027878?

The current status of NCT07027878 (JETi Lower Extremity Venous Thrombosis) is: COMPLETED.

When did JETi Lower Extremity Venous Thrombosis start?

JETi Lower Extremity Venous Thrombosis started on 2020-08-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.